Literature DB >> 11571277

PrPC directly interacts with proteins involved in signaling pathways.

C Spielhaupter1, H M Schätzl.   

Abstract

The cellular prion protein (PrP(C)) is a conserved glycoprotein predominantly expressed in neuronal cells. Its purpose in living cells is still enigmatic. To elucidate on its cellular function, we performed a yeast two-hybrid screen for interactors. We used murine PrP(C) (amino acids 23-231) as bait to search a mouse brain cDNA expression library. Several interaction partners were identified. Three of them with a high homology to known sequences were further characterized. These candidates were the neuronal phosphoprotein synapsin Ib, the adaptor protein Grb2, and the still uncharacterized prion interactor Pint1. The in vivo interaction of the three proteins with PrP(C) was confirmed by co-immunoprecipitation assays with recombinant and authentic proteins in mammalian cells. The binding regions were mapped using truncated PrP constructs. As both synapsin Ib and Grb2 are implicated in neuronal signaling processes, our findings further strengthen the putative role of the prion protein in signal transduction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11571277     DOI: 10.1074/jbc.M103289200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Functional mechanisms of the cellular prion protein (PrP(C)) associated anti-HIV-1 properties.

Authors:  Sandrine Alais; Ricardo Soto-Rifo; Vincent Balter; Henri Gruffat; Evelyne Manet; Laurent Schaeffer; Jean Luc Darlix; Andrea Cimarelli; Graça Raposo; Théophile Ohlmann; Pascal Leblanc
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

Review 2.  De novo mammalian prion synthesis.

Authors:  Federico Benetti; Giuseppe Legname
Journal:  Prion       Date:  2009-10-26       Impact factor: 3.931

3.  Ablation of the cellular prion protein, PrPC, specifically on follicular dendritic cells has no effect on their maturation or function.

Authors:  Laura McCulloch; Karen L Brown; Neil A Mabbott
Journal:  Immunology       Date:  2013-03       Impact factor: 7.397

4.  Prion protein "gamma-cleavage": characterizing a novel endoproteolytic processing event.

Authors:  Victoria Lewis; Vanessa A Johanssen; Peter J Crouch; Genevieve M Klug; Nigel M Hooper; Steven J Collins
Journal:  Cell Mol Life Sci       Date:  2015-08-23       Impact factor: 9.261

5.  NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells.

Authors:  Benoît Schneider; Vincent Mutel; Mathéa Pietri; Myriam Ermonval; Sophie Mouillet-Richard; Odile Kellermann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

6.  Absence of the cellular prion protein exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyelitis.

Authors:  Shigeki Tsutsui; Jennifer N Hahn; Trina A Johnson; Zenobia Ali; Frank R Jirik
Journal:  Am J Pathol       Date:  2008-10       Impact factor: 4.307

Review 7.  Immunotherapy in prion disease.

Authors:  Yvonne Roettger; Yansheng Du; Michael Bacher; Inga Zerr; Richard Dodel; Jan-Philipp Bach
Journal:  Nat Rev Neurol       Date:  2012-12-18       Impact factor: 42.937

Review 8.  Prion protein biosynthesis and its emerging role in neurodegeneration.

Authors:  Oishee Chakrabarti; Aarthi Ashok; Ramanujan S Hegde
Journal:  Trends Biochem Sci       Date:  2009-05-15       Impact factor: 13.807

9.  Olfactory behavior and physiology are disrupted in prion protein knockout mice.

Authors:  Claire E Le Pichon; Matthew T Valley; Magdalini Polymenidou; Alexander T Chesler; Botir T Sagdullaev; Adriano Aguzzi; Stuart Firestein
Journal:  Nat Neurosci       Date:  2008-12-21       Impact factor: 24.884

10.  The cellular prion protein interacts with the tissue non-specific alkaline phosphatase in membrane microdomains of bioaminergic neuronal cells.

Authors:  Myriam Ermonval; Anne Baudry; Florence Baychelier; Elodie Pradines; Mathéa Pietri; Kimimitsu Oda; Benoît Schneider; Sophie Mouillet-Richard; Jean-Marie Launay; Odile Kellermann
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.